Surgical complications of nonsteroidal antiinflammatory drug-induced small bowel ulceration

Journal of the American College of Surgeons

Volumn 185, Issue 3, 1997, Pages 250-254

  Kessler, William F ^a   Shires III, G Tom ^a   Fahey III, Thomas J ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG USE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTESTINE SURGERY; INTESTINE ULCER; LAPAROTOMY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL INTESTINE OBSTRUCTION; SMALL INTESTINE PERFORATION;

EID: 0030768868     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(97)00067-7     Document Type: Article

References (18)

1. Bateman DN. NSAIDs: time to reevaluate gut toxicity. Lancet 1994;343:1051-1052.
2. Soil AH. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 1991;114:307-319.
3. Banerjee AK, Marway JS, Preedy VR, and Peters TJ. Studies of gut mucosal protein synthesis in a non-steroidal antiinflammatory drug (NSAID) model of inflammatory bowel disease. Gut 1992;33(2):242-245.
4. Tokumitsu Y, Lee S, and Ui M. In vitro effects of nonsteroidal antiinflammatory drugs on oxidative phosphorylation in rat mitochondria. Biochem Pharmacol 1977;26:2101-2109.
5. Bjarnason I, Hayllar J, Macpherson A, and Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestines in humans. Gastroenterology 1993;104:1832-1847.
6. Langman MJS, Morgan L, and Worrall A. Use of antiinflammatory drugs by patients admitted with small or large bowel perforation or hemorrhage. Br Med J 1985;290:347-349.
7. Allison MC, Allan G, Howatson MB, Torrance MB, Lee FD, and Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992; 327:749-754.
8. Grosfeld JL, Chaet M, Molinari F, et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg 1996;224:350-357.
9. Morris AJ, Madhok R, Sturrock RD, et al. Enteroscopic diagnosis of small bowel ulceration in patients receiving nonsteroidal anti-inflammatory drugs. Lancet 1991;337:520.
10. Morris AJ, Wasson LA, and MacKenzie JF. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 1992;33: 887-889.
11. Bjarnason I. Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology 1988;94:1070-1074.
12. Matsuhashi N, Yamada A, Hiraishi M, et al. Multiple strictures of the small intestine after long-term nonsteroidal antiinflammatory drug therapy. Am J Gastroenterol 1992;87: 1183-1186.
13. Davies NM. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum 1995;38:1311-1321.
14. Boydstun JS Jr, Gaffey TA, and Bartholomew LG. Clinicopathologic study of non-specific ulcers of the small intestine. Dig Dis Sci 1981;26:911.
15. Aabakken L, Larsen S, and Osnes M. Sucralfate for prevention of naproxen-induced mucosal lesions in the proximal and distal gastrointestinal tract. Scand J Rheumatol 1989;18: 361-368.
16. Aabakken L, Larsen S, and Osnes M. Cimetidine tablets or suspension for the prevention of gastrointestinal mucosal lesions caused by non-steroidal, anti-inflammatory drugs Scand J Rheumatol 1989;18:369-375.
17. Grazioli I, Avossa M, Bogliolo A, et al. Multicenter study of the safety/efficacy of misoprostol in the prevention and treatment of NSAID-induced gastroduodenal lesions. Clin Exp Rheumatol 1993;11:289-294.
18. Bjarnason I, Smethurst P, Fenn CG, et al. Misoprostol reduces indomethacin-induced changes in human small intestinal permeability. Dig Dis Sci 1989;34:407-411.